Expression of cell division markers in the hippocampus in Alzheimer's disease and other nenrodegenerative conditions

Acta Neuropathologica

Volumn 93, Issue 3, 1997, Pages 294-300

  Nagy, Zs ^a   Esiri, M M ^b   Smith, A D ^b  

^a RADCLIFFE INFIRMARY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; Hippocampus; Ki 67

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CELL DIVISION; CHILD; CLINICAL ARTICLE; DENTATE GYRUS; DOWN SYNDROME; GLIA CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CELL DIVISION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION;

EID: 0031043049     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050617     Document Type: Article

References (34)

1. Araujo DM, Cotman CW (1992) Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 569: 141-145
2. Arendt T, Holzer M, Grossmann A, Zedlick D, Bruckner MK (1995) Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimers disease. Neuroscience 68: 5-18
3. Ariza A, Mate JL, Fernandez-Vasalo A, Gomez-Plaza C, Perez-Piteira J, Pujol M, Navas-Palacios JJ (1994) p53 and proliferating cell nuclear antigen expression in JC virus-infected cells of progressive multifocal leukoencephalopathy. Hum Pathol 25: 1341-1345
4. Barbareschi M, Girlando S, Mauri FA, Arrigoni G, Laurino L, Dalla-Palma P, Doglioni C (1992) Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol 166: 343-350
5. Boulikas T (1995) Phosphorylation of transcription factors and control of the cell cycle. Crit Rev Eukaryot Gene Expr 5: 1-77
6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
7. Bravo R (1986) Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 163: 287-293
8. Coltrera MD, Gown AM (1991) PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem 39: 23-30
9. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J (1993) Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 13: 2540-2550
10. Cummings BJ, Su JH, Cotman CW (1993) Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease. Exp Neurol 124: 315-325
11. ras in Alzheimer pathology. NeuroReport 6: 1313-1316
12. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189: 167-169
13. Hyman BT, Van-Hoesen GW, Wolozin BL, Davies P, Kromer LJ, Damasio AR (1988) Alz-50 antibody recognizes Alzheimer-related neuronal changes. Ann Neurol 23: 371-379
14. Korkolopoulou P, Christodoulou P, Papanikolaou A, Thomas-Tsagli E (1993) Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections. Am J Surg Pathol 17: 912-919
15. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358: 15-16
16. Masliah F, Mallory M, Alford M, Hansen LA, Saitoh T (1993) Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease. Lab Invest 69: 562-569
17. Mercer WE, Shields MT, Lin D, Appella E, Ullrich SJ (1991) Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 88: 1958-1962
18. Miyake T, Okada M, Kitamura T (1992) Reactive proliferation of astrocytes studied by immunohistochemistry for proliferating cell nuclear antigen. Brain Res 590: 300-302
19. Morris CS, Esiri MM, Sprinkle TJ, Gregson N (1994) Oligodendrocyte reactions and cell proliferation markers in human demyelinating diseases. Neuropathol Appl Neurobiol 20: 272-281
20. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD (1995) Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 6: 21-31
21. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708
22. Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246: 603-608
23. Prayoonwiwat N, Rodriguez M (1993) The potential for oligodendrocyte proliferation during demyelinating disease. J Neuropathol Exp Neurol 52: 55-63
24. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B (1987) Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326: 517-520
25. Ross ME (1996) Cell division and the nervous system: regulating the cycle from neural differentiation to death. Trends Neurosci 19: 62-68
26. Samuel W, Masliah E, Hill LR, Butters N, Terry R (1994) Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology 44: 2081-2088
27. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr (1995) Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133: 225-230
28. Smith TW, Lippa CF 81995) Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 54: 297-303
29. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38: 359-364
30. Ucker DS (1991) Death by suicide: one way to go in mammalian cellular development? New Biol 3: 103-109
31. Verri A, Verzeletti S, Mazzarello P, Spadari S, Negri M, Bunone G, Della-Valle G, Hubscher U, Focher F (1992) DNA synthesis enzymes and proliferating cell nuclear antigen in normal and neoplastic nerve cells. Anticancer Res 12: 1099-1105
32. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70: 523-526
33. Wakabayashi K, Honer WG, Masliah E (1994) Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease. Brain Res 667: 24-32
34. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344: 769-772